Stockscreener 앱 받기
13.16
1.20%
-0.16
전일 마감가:
$13.32
열려 있는:
$13
하루 거래량:
1,348
Relative Volume:
0.11
시가총액:
$901.75M
수익:
$277.56M
순이익/손실:
$-13.33M
주가수익비율:
-69.26
EPS:
-0.19
순현금흐름:
$-6.54M
1주 성능:
-4.36%
1개월 성능:
-18.46%
6개월 성능:
+46.87%
1년 성능:
+57.93%
1일 변동 폭
$13.00
$13.16
1주일 범위
$13.00
$13.82
52주 변동 폭
$7.31
$17.08
Pharming Group N V Adr Stock (PHAR) Company Profile
PHAR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PHAR
Pharming Group N V Adr
|
13.16 | 912.62M | 277.56M | -13.33M | -6.54M | -0.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.52 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
626.68 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.19 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.00 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.24 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Pharming Group N V Adr Stock (PHAR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-09 | 개시 | Jefferies | Buy |
Pharming Group N V Adr 주식(PHAR)의 최신 뉴스
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Update - MarketBeat
Pharming Group (PHAR) to Release Earnings on Thursday - Defense World
Pharming Group (NASDAQ:PHAR) Upgraded at Weiss Ratings - Defense World
Pharming Group (NASDAQ:PHAR) Shares Gap DownHere's Why - MarketBeat
Pharming Group (NASDAQ:PHAR) Shares Up 9.5%What's Next? - MarketBeat
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Down 71.8% in September - MarketBeat
Pharming Group (NASDAQ:PHAR) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Short Interest in Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Increases By 64.2% - MarketBeat
Pharming Group (NASDAQ:PHAR) Stock Price Down 4.6%What's Next? - MarketBeat
Pharming Group (NASDAQ:PHAR) Stock Price Up 7%Still a Buy? - MarketBeat
Pharming Group (NASDAQ:PHAR) Shares Gap UpTime to Buy? - MarketBeat
Pharming Group (NASDAQ:PHAR) Sees Large Volume IncreaseTime to Buy? - MarketBeat
QURE Stock Skyrockets on Meeting Goals in Huntington's Disease Study - The Globe and Mail
Pharming Group (NASDAQ:PHAR) Shares Gap Up – Still a Buy? - Defense World
Pharming Group (NASDAQ:PHAR) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Pharming Group (NASDAQ:PHAR) Stock Price Down 4.4%What's Next? - MarketBeat
Short Interest in Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Increases By 378.6% - MarketBeat
RAPP Stock Soars 62% in a Week on Meeting Phase II Epilepsy Study Goal - The Globe and Mail
Pharming Group (NASDAQ:PHAR) Stock Price Up 5%Here's Why - MarketBeat
Beat the Market the Zacks Way: Oracle, Intellia, Pharming Group in Focus - Zacks Investment Research
Pharming Group appoints Kenneth Lynard as Chief Financial Officer - GlobeNewswire Inc.
Catalyst Pharmaceuticals Settles Firdapse Patent Litigation With Lupin - The Globe and Mail
Pharming Group (NASDAQ:PHAR) Shares Gap Up – Should You Buy? - Defense World
Wall Street Analysts See a 142.26% Upside in Pharming Group (PHAR): Can the Stock Really Move This High? - ca.finance.yahoo.com
Wall Street Analysts Think Pharming Group (PHAR) Could Surge 145.75%: Read This Before Placing a Bet - Yahoo Finance
Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume on Earnings Beat - Defense World
New Strong Buy Stocks for August 1st - TradingView
Pharming Group (NASDAQ:PHAR) Shares Gap Up After Earnings Beat - Defense World
Best Momentum Stocks to Buy for July 25th - TradingView
New Strong Buy Stocks for July 25th - TradingView
New Strong Buy Stocks for July 17th - MSN
Best Momentum Stocks to Buy for July 17th - NewsBreak: Local News & Alerts
PHAR stock hits 52-week high at $11.14 amid robust growth By Investing.com - Investing.com South Africa
PHAR stock hits 52-week high at $11.14 amid robust growth - Investing.com India
Pharming To Attend The H.C. Wainwright BioConnect Investor Conference 2023 - Barchart.com
SpringWorks Therapeutics (SWTX) Soars 9.0%: Is Further Upside Left in the Stock? - Nasdaq
H.C. Wainwright maintains Buy on Pharming with $37 price target - Investing.com
Pharming Group stock gains on KL1333’s blockbuster potential, says RBC - Investing.com
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last? - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Why Earnings Season Could Be Great for Pharming Group (PHAR) - Yahoo Finance
What is the current Price Target and Forecast for Pharming Group (PHAR) - Zacks Investment Research
Pharming Group N V Adr (PHAR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.18%
0.56%
자본화:
|
볼륨(24시간):